Ibrutinib-associated atrial fibrillation treatment with catheter ablation
HeartRhythm Case Rep
.
2021 Nov 15;7(11):713-716.
doi: 10.1016/j.hrcr.2021.08.003.
eCollection 2021 Nov.
Authors
Ridhima Kapoor
1
,
Muhammad Fazal
1
,
Paul Cheng
1
,
Ronald Witteles
1
,
June-Wha Rhee
1
,
Tina Baykaner
1
Affiliation
1
Department of Medicine, Stanford University School of Medicine, Stanford, California.
PMID:
34820264
PMCID:
PMC8602082
DOI:
10.1016/j.hrcr.2021.08.003
No abstract available
Keywords:
Atrial fibrillation; Catheter ablation; Ibrutinib; Lymphoma; Tyrosine kinase inhibitors.
Publication types
Case Reports
Grants and funding
K08 HL148540/HL/NHLBI NIH HHS/United States
K08 HL153798/HL/NHLBI NIH HHS/United States
K23 HL145017/HL/NHLBI NIH HHS/United States